PHLEBOPROTECTORS BASED ON FLAVONOIDS: DOSAGE FORMS, BIOPHARMACEUTICAL CHARACTERISTICS, TECHNOLOGICAL FEATURES
Micronized purified flavonoid fraction (MPFF) is the original phlebotropic drug. Its marketed form (Detralex®) consists of 90% diosmin and 10% of other flavonoids. Calculated as hesperidin, it is the most widely used drug today. Diosmin and hesperidin, which are parts of the majority of venoactive d...
Saved in:
| Main Authors: | E. F. Stepanova, I. P. Remezova, A. M. Shevchenko, A. V. Morozov, V. K. Maltseva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2021-05-01
|
| Series: | Фармация и фармакология (Пятигорск) |
| Subjects: | |
| Online Access: | https://www.pharmpharm.ru/jour/article/view/769 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological activity of polyphenolic connections in the conditions of alcoholic intoxication
by: A. V. Krikova, et al.
Published: (2011-10-01) -
Case Report: Micronized purified flavonoid fraction [Daflon]-induced bradycardia
by: Jhennyfer Aline Lima Rodrigues, et al.
Published: (2025-08-01) -
The neuroprotective effects of hesperidin and diosmin in neurological disorders via targeting various signaling pathways
by: Nikoo Abharian, et al.
Published: (2025-07-01) -
Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins
by: A. V. Voronkov, et al.
Published: (2019-04-01) -
Study of basis-transmitter influence on biopharmaceutical properties of diltiazem nasal dosage form
by: V. V. Gladyshev, et al.
Published: (2013-04-01)